{
  "2019_Pipeline_Status":[
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03634007",
      "Drug Name": "AAVrh.10hAPOE2",
      "Status": "Recruiting",
      "Biomarkers": "CSF or PET",
      "MOA Class": 4,
      "MOA Category": "c",
      "CADRO MOA Category": "Q",
      "Geography": 1
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT01677572",
      "Drug Name": "Aducanumab (BIIB037)",
      "Status": "Terminated (based on futility analysis conducted on Phase 3 trials, not based on safety concerns",
      "Biomarkers": "PET",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03635047",
      "Drug Name": "AL002",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 4,
      "MOA Category": "f",
      "CADRO MOA Category": "F",
      "Geography": "1, 3, 7"
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03822208",
      "Drug Name": "AL003",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 4,
      "MOA Category": "f",
      "CADRO MOA Category": "F",
      "Geography": 7
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03748303",
      "Drug Name": "Allopregnanolone (Allo-IM)",
      "Status": "Not yet recruiting",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "c, d",
      "CADRO MOA Category": "L, E",
      "Geography": 1
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT02502253",
      "Drug Name": "BDPP (Bioactive Dietary Polyphenol Preparation)",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "J?",
      "Geography": 1
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03056729",
      "Drug Name": "BIIB076",
      "Status": "Ongoing",
      "Biomarkers": "PET",
      "MOA Class": 4,
      "MOA Category": "b",
      "CADRO MOA Category": "B",
      "Geography": 1
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03802162",
      "Drug Name": "CKD-355",
      "Status": "Completed",
      "Biomarkers": "no",
      "MOA Class": "undisclosed",
      "MOA Category": "undisclosed",
      "CADRO MOA Category": "? Undisclosed",
      "Geography": 5
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT02353598",
      "Drug Name": "crenezumab",
      "Status": "Completed (terminated?)",
      "Biomarkers": "PET",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": 1,
      "Geography": ""
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03522129",
      "Drug Name": "CT1812 (Elayta)",
      "Status": "Recruiting",
      "Biomarkers": "PET",
      "MOA Class": 3,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": 1
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03752294",
      "Drug Name": "Dabigatran",
      "Status": "Not yet recruiting",
      "Biomarkers": "PET or CSF",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "K",
      "Geography": 1
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03757325",
      "Drug Name": "DNL747",
      "Status": "Ongoing",
      "Biomarkers": "CSF or PET",
      "MOA Class": 3,
      "MOA Category": "c, f",
      "CADRO MOA Category": "F",
      "Geography": "1, 3"
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03706885",
      "Drug Name": "Efavirenz",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "a",
      "CADRO MOA Category": "F (infection/immunity)",
      "Geography": 1
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03274817",
      "Drug Name": "Escitalopram, Venlafaxine",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 1,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 1
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT02600130",
      "Drug Name": "hMSCs (Longeveron Mesenchymal Stem Cells)",
      "Status": "Ongoing",
      "Biomarkers": "PET",
      "MOA Class": "stem cell",
      "MOA Category": "g",
      "CADRO MOA Category": "NGB",
      "Geography": 1
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT02462161",
      "Drug Name": "Insulin aspart Intranasal",
      "Status": "Completed",
      "Biomarkers": "No",
      "MOA Class": 3,
      "MOA Category": "d",
      "CADRO MOA Category": "J",
      "Geography": ""
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03838185",
      "Drug Name": "J147",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "M",
      "Geography": 1
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03375697",
      "Drug Name": "JNJ-63733657",
      "Status": "Ongoing",
      "Biomarkers": "CSF",
      "MOA Class": 4,
      "MOA Category": "b",
      "CADRO MOA Category": "B",
      "Geography": 3
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03668405",
      "Drug Name": "Lu AF20513",
      "Status": "Terminated (based on new efficacy data from another study",
      "Biomarkers": "no",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT02388152",
      "Drug Name": "Lu AF20513",
      "Status": "Terminated (based on new efficacy data from another study",
      "Biomarkers": "CSF",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03819699",
      "Drug Name": "Lu AF20513",
      "Status": "Terminated (based on new efficacy data from another study",
      "Biomarkers": "CSF amyloid and tau AND amyloid PET",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT02624778",
      "Drug Name": "LY3002813 (donanemab)",
      "Status": "Completed",
      "Biomarkers": "PET",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03019536",
      "Drug Name": "LY3303560 (zagotenemab)",
      "Status": "Completed",
      "Biomarkers": "no",
      "MOA Class": 4,
      "MOA Category": "b",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03720548",
      "Drug Name": "LY3372993",
      "Status": "Completed",
      "Biomarkers": "PET",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03740178",
      "Drug Name": "MK-4334",
      "Status": "Not yet recruiting",
      "Biomarkers": "no",
      "MOA Class": "undisclosed",
      "MOA Category": "undisclosed",
      "CADRO MOA Category": "?",
      "Geography": "?"
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03298672",
      "Drug Name": "NDX-1017",
      "Status": "Completed",
      "Biomarkers": "no",
      "MOA Class": 4,
      "MOA Category": "g",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03008161",
      "Drug Name": "NPT088",
      "Status": "Completed",
      "Biomarkers": "PET",
      "MOA Class": 4,
      "MOA Category": "a, b",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03277573",
      "Drug Name": "Salsalate",
      "Status": "Recruiting",
      "Biomarkers": "PET",
      "MOA Class": 3,
      "MOA Category": "f",
      "CADRO MOA Category": "F",
      "Geography": ""
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT02471833",
      "Drug Name": "Telmisartan (20mg and 40mg)",
      "Status": "Recruiting",
      "Biomarkers": "No",
      "MOA Class": 3,
      "MOA Category": "c, f",
      "CADRO MOA Category": "K",
      "Geography": ""
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03698695",
      "Drug Name": "THN 201 (donepezil and mefloquine combo)",
      "Status": "Ongoing",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "e",
      "CADRO MOA Category": "D, F?",
      "Geography": 3
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT01966666",
      "Drug Name": "TPI-287",
      "Status": "Ongoing",
      "Biomarkers": "No",
      "MOA Class": 3,
      "MOA Category": "b",
      "CADRO MOA Category": "B",
      "Geography": 1
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03056495",
      "Drug Name": "Vorinostat",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "F (infection/immunity)",
      "Geography": 3
    },
    {
      "Phase": "Phase 1|Phase 2",
      "NCT #": "NCT03117738",
      "Drug Name": "AstroStem",
      "Status": "Completed",
      "Biomarkers": "no",
      "MOA Class": "stem cell",
      "MOA Category": "g",
      "CADRO MOA Category": "NGB",
      "Geography": 1
    },
    {
      "Phase": "Phase 1|Phase 2",
      "NCT #": "NCT03493282",
      "Drug Name": "CT1812",
      "Status": "Recruiting",
      "Biomarkers": "CSF or PET",
      "MOA Class": 3,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": 1
    },
    {
      "Phase": "Phase 1|Phase 2",
      "NCT #": "NCT03801642",
      "Drug Name": "Dapagliflozin",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": "3?",
      "MOA Category": "d",
      "CADRO MOA Category": "J",
      "Geography": 1
    },
    {
      "Phase": "Phase 1|Phase 2",
      "NCT #": "NCT02414607",
      "Drug Name": "Elderberry Juice",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "c, f",
      "CADRO MOA Category": "M",
      "Geography": 1
    },
    {
      "Phase": "Phase 1|Phase 2",
      "NCT #": "NCT02054208",
      "Drug Name": "hUCB-MSCs (human umbilical cord blood derived mesenchymal stem cells) NEUROSTEM",
      "Status": "Recruiting",
      "Biomarkers": "PET",
      "MOA Class": "stem cell",
      "MOA Category": "g",
      "CADRO MOA Category": "NGB",
      "Geography": 5
    },
    {
      "Phase": "Phase 1|Phase 2",
      "NCT #": "NCT03172117",
      "Drug Name": "hUCB-MSCs (human umbilical cord blood derived mesenchymal stem cells) NEUROSTEM",
      "Status": "Recruiting, extension",
      "Biomarkers": "no",
      "MOA Class": "stem cell",
      "MOA Category": "g",
      "CADRO MOA Category": "NGB",
      "Geography": 5
    },
    {
      "Phase": "Phase 1|Phase 2",
      "NCT #": "NCT02672306",
      "Drug Name": "Human UCMSCs (Human Umbilical Cord-Derived Mesenchymal Stem Cells)",
      "Status": "Ongoing",
      "Biomarkers": "No",
      "MOA Class": "stem cell",
      "MOA Category": "g",
      "CADRO MOA Category": "NGB",
      "Geography": 5
    },
    {
      "Phase": "Phase 1|Phase 2",
      "NCT #": "NCT03186989",
      "Drug Name": "IONIS MAPTRx (BIIB080)",
      "Status": "Recruiting",
      "Biomarkers": "CSF",
      "MOA Class": 4,
      "MOA Category": "b",
      "CADRO MOA Category": "NGB (but include in main table and solar per Dr.C)",
      "Geography": "1, 3"
    },
    {
      "Phase": "Phase 1|Phase 2",
      "NCT #": "NCT03069014",
      "Drug Name": "LM11A-31-BHS",
      "Status": "Recruiting",
      "Biomarkers": "CSF",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "L",
      "Geography": "3, 4"
    },
    {
      "Phase": "Phase 1|Phase 2",
      "NCT #": "NCT02925650",
      "Drug Name": "Posiphen",
      "Status": "Recruiting",
      "Biomarkers": "CSF",
      "MOA Class": 3,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": 1
    },
    {
      "Phase": "Phase 1|Phase 2",
      "NCT #": "NCT03101085",
      "Drug Name": "S-equol (AUS-131)",
      "Status": "Recruiting",
      "Biomarkers": "No",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "L or M?",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02579252",
      "Drug Name": "AADvac1",
      "Status": "Completed",
      "Biomarkers": "CSF",
      "MOA Class": 4,
      "MOA Category": "b",
      "CADRO MOA Category": "B",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03712787",
      "Drug Name": "ABBV-8E12",
      "Status": "Enrolling by invitation - Extension study",
      "Biomarkers": "no",
      "MOA Class": 4,
      "MOA Category": "b",
      "CADRO MOA Category": "B",
      "Geography": "1, 3, 7"
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02880956",
      "Drug Name": "ABBV-8E12",
      "Status": "Ongoing",
      "Biomarkers": "PET",
      "MOA Class": 4,
      "MOA Category": "b",
      "CADRO MOA Category": "B",
      "Geography": "1, 3, 6, 7"
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03461276",
      "Drug Name": "ABvac40",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": 3
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03790982",
      "Drug Name": "AD-35",
      "Status": "Active, not recruiting",
      "Biomarkers": "no",
      "MOA Class": 1,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 5
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03625401",
      "Drug Name": "AD-35",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 1,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03639987",
      "Drug Name": "Aducanumab (EVOLVE)",
      "Status": "Terminated (based on futility analysis conducted on Phase 3 trials and not based on safety concerns)",
      "Biomarkers": "PET",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03533257",
      "Drug Name": "AMX0035 (combination of Tauroursodeoxycholic Acid and Sodium Phenylbutyrate)",
      "Status": "Recruiting",
      "Biomarkers": "PET or CSF, FDG-PET or vMRI",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "M, H",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02756858",
      "Drug Name": "ANAVEX2-73",
      "Status": "Ongoing-extension",
      "Biomarkers": "No",
      "MOA Class": 3,
      "MOA Category": "a, b, f",
      "CADRO MOA Category": "F, M",
      "Geography": 7
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03806478",
      "Drug Name": "APH-1105",
      "Status": "Not yet recruiting",
      "Biomarkers": "CT or MRI",
      "MOA Class": 3,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03625622",
      "Drug Name": "AR1001",
      "Status": "Recruiting",
      "Biomarkers": "MRI or CT",
      "MOA Class": 3,
      "MOA Category": "a",
      "CADRO MOA Category": "M",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02886494",
      "Drug Name": "BAC (IV)",
      "Status": "Completed",
      "Biomarkers": "No",
      "MOA Class": "undisclosed",
      "MOA Category": "undisclosed",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02467413",
      "Drug Name": "BAC (topical)",
      "Status": "Withdrawn (at sponsor's decision)",
      "Biomarkers": "No",
      "MOA Class": "undisclosed",
      "MOA Category": "undisclosed",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02292238",
      "Drug Name": "Benfotiamine",
      "Status": "Ongoing",
      "Biomarkers": "PET",
      "MOA Class": 1,
      "MOA Category": "d",
      "CADRO MOA Category": "J",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02788513",
      "Drug Name": "BI 425809",
      "Status": "Completed",
      "Biomarkers": "no",
      "MOA Class": 1,
      "MOA Category": "e",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03352557",
      "Drug Name": "BIIB092",
      "Status": "Ongoing",
      "Biomarkers": "amyloid beta positivity confirmed at screening",
      "MOA Class": 4,
      "MOA Category": "b",
      "CADRO MOA Category": "B",
      "Geography": "1, 3, 6, 7"
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03817684",
      "Drug Name": "BPN14770",
      "Status": "Ongoing",
      "Biomarkers": "no",
      "MOA Class": "3?",
      "MOA Category": "f",
      "CADRO MOA Category": "M",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03560245",
      "Drug Name": "Bryostatin IV infusion",
      "Status": "Completed",
      "Biomarkers": "no",
      "MOA Class": "3?",
      "MOA Category": "d",
      "CADRO MOA Category": "F, E?",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02646982",
      "Drug Name": "Candesartan",
      "Status": "Recruiting",
      "Biomarkers": "CSF or PET",
      "MOA Class": 3,
      "MOA Category": "a, c, d",
      "CADRO MOA Category": "K",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT00876863",
      "Drug Name": "CERE-110",
      "Status": "Completed (terminated?)",
      "Biomarkers": "no",
      "MOA Class": 4,
      "MOA Category": "c",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02491268",
      "Drug Name": "Cilostazol",
      "Status": "Ongoing",
      "Biomarkers": "No",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "M",
      "Geography": 6
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT01998841",
      "Drug Name": "crenezumab",
      "Status": "Ongoing",
      "Biomarkers": "No",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": 2
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03507790",
      "Drug Name": "CT1812",
      "Status": "Recruiting",
      "Biomarkers": "PET or CSF",
      "MOA Class": 3,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": "1, 7"
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT01811381",
      "Drug Name": "Curcumin + aerobic yoga",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "M",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03752463",
      "Drug Name": "DAOI",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 1,
      "MOA Category": "e",
      "CADRO MOA Category": 5,
      "Geography": 5
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03234686",
      "Drug Name": "Deferiprone",
      "Status": "Recruiting",
      "Biomarkers": "PET",
      "MOA Class": 3,
      "MOA Category": "a, c",
      "CADRO MOA Category": "M, A?",
      "Geography": 7
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03613844",
      "Drug Name": "DHA (docosahexaenoic acid)",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "M",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03055741",
      "Drug Name": "DHP1401",
      "Status": "Completed",
      "Biomarkers": "No",
      "MOA Class": 1,
      "MOA Category": "d",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02792257",
      "Drug Name": "Dronabinol",
      "Status": "Recruiting",
      "Biomarkers": "No",
      "MOA Class": 2,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02322021",
      "Drug Name": "E2609 (elenbecestat)",
      "Status": "Ongoing (but we know trial was terminated - Mission-AD)",
      "Biomarkers": "PET",
      "MOA Class": 3,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02500784",
      "Drug Name": "Formoterol (inhaled)",
      "Status": "Suspended (funding ran out before study started, prior PI left institution)",
      "Biomarkers": "No",
      "MOA Class": 3,
      "MOA Category": "d",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02033941",
      "Drug Name": "Grapeseed Extract",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "M",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03520998",
      "Drug Name": "GRF6019",
      "Status": "Completed (another trial in severe AD still ongoing)",
      "Biomarkers": "no",
      "MOA Class": 4,
      "MOA Category": "f",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03765762",
      "Drug Name": "GRF6019",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 4,
      "MOA Category": "f",
      "CADRO MOA Category": "E",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03184467",
      "Drug Name": "GV1001",
      "Status": "Unknown",
      "Biomarkers": "no",
      "MOA Class": 4,
      "MOA Category": "a, d",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02833792",
      "Drug Name": "hMSCs (Human Mesenchymal Stem Cells)",
      "Status": "Recruiting (changed from ongoing to recruiting)",
      "Biomarkers": "PET",
      "MOA Class": "stem cell",
      "MOA Category": "g",
      "CADRO MOA Category": "NGB",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02513706",
      "Drug Name": "Human UCMSCs (Human Umbilical Cord-Derived Mesenchymal Stem Cells)",
      "Status": "Ongoing",
      "Biomarkers": "No",
      "MOA Class": "stem cell",
      "MOA Category": "g",
      "CADRO MOA Category": "NGB",
      "Geography": 2
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03363269",
      "Drug Name": "ID1201",
      "Status": "Completed",
      "Biomarkers": "PET",
      "MOA Class": 3,
      "MOA Category": "a",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02503501",
      "Drug Name": "Insulin glulisine intranasal",
      "Status": "Ongoing",
      "Biomarkers": "CT or MRI",
      "MOA Class": 3,
      "MOA Category": "d",
      "CADRO MOA Category": "J",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03001557",
      "Drug Name": "Lemborexant (E2006)",
      "Status": "Ongoing",
      "Biomarkers": "no",
      "MOA Class": 2,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": "1, 3, 6"
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03489044",
      "Drug Name": "Levetiracetam",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "M",
      "Geography": 3
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02002819",
      "Drug Name": "levetiracetam",
      "Status": "Recruiting",
      "Biomarkers": "No",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "M",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03461861",
      "Drug Name": "Levetiracetam",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "M",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT01843075",
      "Drug Name": "Liraglutide",
      "Status": "Ongoing",
      "Biomarkers": "No",
      "MOA Class": 3,
      "MOA Category": "d",
      "CADRO MOA Category": "J",
      "Geography": 3
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02129348",
      "Drug Name": "Lithium",
      "Status": "Recruiting",
      "Biomarkers": "No",
      "MOA Class": 2,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03062449",
      "Drug Name": "L-Serine",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "F? M?",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03649724",
      "Drug Name": "Lupron (Leuprolide Acetate Depot) + ACheI (2014 study showed that in a sub population of female subjects on AchEI, showed cognitive improvement; basis for this current study)",
      "Status": "Not yet recruiting",
      "Biomarkers": "PET",
      "MOA Class": "3?",
      "MOA Category": "d",
      "CADRO MOA Category": "L?",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03367403",
      "Drug Name": "LY3002813",
      "Status": "Ongoing",
      "Biomarkers": "PET",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03518073",
      "Drug Name": "LY3303560 (zagotenemab)",
      "Status": "Ongoing",
      "Biomarkers": "no",
      "MOA Class": 4,
      "MOA Category": "b",
      "CADRO MOA Category": 2,
      "Geography": "1, 5"
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02380573",
      "Drug Name": "Methylene Blue",
      "Status": "Suspended (pending enrollment of new subjects if new funding obtained)",
      "Biomarkers": "No",
      "MOA Class": 3,
      "MOA Category": "b",
      "CADRO MOA Category": 2,
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03038035",
      "Drug Name": "MLC901 (Neuroaid)",
      "Status": "Unknown (status was recruiting)",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "c, f",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03402503",
      "Drug Name": "Montelukast VersaFilm (buccal film)",
      "Status": "Recruiting",
      "Biomarkers": "CT or MRI",
      "MOA Class": 1,
      "MOA Category": "f",
      "CADRO MOA Category": "F",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03044249",
      "Drug Name": "MP-101",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 2,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03828747",
      "Drug Name": "Semorinemab (RO7105705; MTAU9937A)",
      "Status": "Recruiting",
      "Biomarkers": "CSF or PET",
      "MOA Class": 4,
      "MOA Category": "b",
      "CADRO MOA Category": "B",
      "Geography": "1, 3, 4"
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03538522",
      "Drug Name": "NA-831(Traneurocin)",
      "Status": "Not yet recruiting",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "?",
      "Geography": 7
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03402659",
      "Drug Name": "neflamapimod (VX-745)",
      "Status": "Completed",
      "Biomarkers": "CSF AB and TAU",
      "MOA Class": 3,
      "MOA Category": "f",
      "CADRO MOA Category": "F",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03435861",
      "Drug Name": "Neflamapimod (VX-745)",
      "Status": "Recruiting",
      "Biomarkers": "PET or CSF",
      "MOA Class": 3,
      "MOA Category": "f",
      "CADRO MOA Category": "F",
      "Geography": 3
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03061474",
      "Drug Name": "Nicotinamide",
      "Status": "Recruiting",
      "Biomarkers": "CSF",
      "MOA Class": 3,
      "MOA Category": "b, c",
      "CADRO MOA Category": "B",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02720445",
      "Drug Name": "Nicotine Transdermal Patch",
      "Status": "Recruiting",
      "Biomarkers": "No",
      "MOA Class": 1,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02947893",
      "Drug Name": "Nilotinib",
      "Status": "Active, not recruiting",
      "Biomarkers": "CSF, CT or MRI",
      "MOA Class": 3,
      "MOA Category": "a, b",
      "CADRO MOA Category": "F",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03319810",
      "Drug Name": "Octagam 10%",
      "Status": "Completed",
      "Biomarkers": "PET",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT01953705",
      "Drug Name": "Omega 3 PUFA (polyunsaturated fatty acid)",
      "Status": "Ongoing",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "M",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03118947",
      "Drug Name": "Pimavanserin",
      "Status": "Completed",
      "Biomarkers": "no",
      "MOA Class": 2,
      "MOA Category": "e",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02615002",
      "Drug Name": "Piromelatine",
      "Status": "Ongoing",
      "Biomarkers": "CT or MRI",
      "MOA Class": 1,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03710642",
      "Drug Name": "Prazosin",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 2,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03748706",
      "Drug Name": "PTI-125",
      "Status": "Completed",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "c, f",
      "CADRO MOA Category": "A",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02359552",
      "Drug Name": "Rasagiline",
      "Status": "Completed",
      "Biomarkers": "FDG-PET",
      "MOA Class": 3,
      "MOA Category": "a, c, d",
      "CADRO MOA Category": "J",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT01703117",
      "Drug Name": "Riluzole",
      "Status": "Recruiting",
      "Biomarkers": "No",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "D",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03462121",
      "Drug Name": "RPh201",
      "Status": "Recruiting",
      "Biomarkers": "MRI or CT",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "E?",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT01409915",
      "Drug Name": "Sagramostim (GM-CSF) - Leukine",
      "Status": "Ongoing (trial cacncelled?)",
      "Biomarkers": "PET",
      "MOA Class": 4,
      "MOA Category": "a, c",
      "CADRO MOA Category": "F, A",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03289143",
      "Drug Name": "Semorinemab (RO7105705; MTAU9937A)",
      "Status": "Ongoing",
      "Biomarkers": "PET or CSF",
      "MOA Class": 4,
      "MOA Category": "b",
      "CADRO MOA Category": "B",
      "Geography": "1, 3, 4, 7"
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02580305",
      "Drug Name": "SUVN-502",
      "Status": "Completed (failed; shown not to be efficacious)",
      "Biomarkers": "No",
      "MOA Class": 1,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02085265",
      "Drug Name": "Telmisartan & Perindopril",
      "Status": "Recruiting",
      "Biomarkers": "MRI or CT",
      "MOA Class": 3,
      "MOA Category": "c, f",
      "CADRO MOA Category": "K",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03417986",
      "Drug Name": "Thiethylperazine (TEP)",
      "Status": "Ongoing",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": 3
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03531710",
      "Drug Name": "UB-311",
      "Status": "Terminated (based on review of baseline data, and the treatment assignment error issue)",
      "Biomarkers": "no",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": 5
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03282916",
      "Drug Name": "Valacyclovir",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "c, f",
      "CADRO MOA Category": "F",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02997982",
      "Drug Name": "Valacyclovir",
      "Status": "Recruiting",
      "Biomarkers": "PET, APOE4, CT, MRI, SPECT or PET/CT",
      "MOA Class": 3,
      "MOA Category": "c, f",
      "CADRO MOA Category": "F",
      "Geography": 3
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02727699",
      "Drug Name": "Xanamem (UE2343)",
      "Status": "Completed (failed)",
      "Biomarkers": "No",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "L or M?",
      "Geography": ""
    },
    {
      "Phase": "Phase 2|Phase 3",
      "NCT #": "NCT01561053",
      "Drug Name": "Albumin & Immuneglobulin (IVIG) Plasmapheresis",
      "Status": "Completed",
      "Biomarkers": "No",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": ""
    },
    {
      "Phase": "Phase 2|Phase 3",
      "NCT #": "NCT03790709",
      "Drug Name": "ANAVEX2-73",
      "Status": "Recruiting",
      "Biomarkers": "PET or CSF",
      "MOA Class": 3,
      "MOA Category": "a, b, f",
      "CADRO MOA Category": "D, M",
      "Geography": 7
    },
    {
      "Phase": "Phase 2|Phase 3",
      "NCT #": "NCT03226522",
      "Drug Name": "AXS-05 (DM + bupropion)",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 2,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": "1, 7"
    },
    {
      "Phase": "Phase 2|Phase 3",
      "NCT #": "NCT03605667",
      "Drug Name": "BHV4157 (troriluzole)",
      "Status": "Ongoing",
      "Biomarkers": "MRI",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "M",
      "Geography": 1
    },
    {
      "Phase": "Phase 2|Phase 3",
      "NCT #": "NCT03620981",
      "Drug Name": "Brexpiprazole",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 2,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 6
    },
    {
      "Phase": "Phase 2|Phase 3",
      "NCT #": "NCT02565511",
      "Drug Name": "CAD106, CNP520 (why is this still listed as recruiting?",
      "Status": "Recruiting",
      "Biomarkers": "APOE4",
      "MOA Class": "3, 4",
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": "1, 3, 7"
    },
    {
      "Phase": "Phase 2|Phase 3",
      "NCT #": "NCT03131453",
      "Drug Name": "CNP520 (Umibecestate) (Generation 2 - why still listed as ongoing?)",
      "Status": "Ongoing",
      "Biomarkers": "PET or CSF",
      "MOA Class": 3,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": "1, 2, 3, 5, 6, 7"
    },
    {
      "Phase": "Phase 2|Phase 3",
      "NCT #": "NCT03823404",
      "Drug Name": "COR388",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "f",
      "CADRO MOA Category": "F",
      "Geography": ""
    },
    {
      "Phase": "Phase 2|Phase 3",
      "NCT #": "NCT01760005",
      "Drug Name": "Gantenerumab & Solanezumab",
      "Status": "Recruiting (changed from ongoing to recruiting)",
      "Biomarkers": "No",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": "1, 2, 3, 5, 6, 7"
    },
    {
      "Phase": "Phase 2|Phase 3",
      "NCT #": "NCT03090516",
      "Drug Name": "Ginkgo Biloba",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 1,
      "MOA Category": "d",
      "CADRO MOA Category": "J, K ?",
      "Geography": 5
    },
    {
      "Phase": "Phase 2|Phase 3",
      "NCT #": "NCT02719327",
      "Drug Name": "Icosapent ethyl (IPE) (Vascepa)",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "M",
      "Geography": 1
    },
    {
      "Phase": "Phase 2|Phase 3",
      "NCT #": "NCT02913664",
      "Drug Name": "Losartan, Amlodipine, Atorvastatin + exercise (all count as 1 agent)",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "f, d",
      "CADRO MOA Category": "K",
      "Geography": 1
    },
    {
      "Phase": "Phase 2|Phase 3",
      "NCT #": "NCT02351882",
      "Drug Name": "Nabilone",
      "Status": "Completed (success; showed reduced agitation and improvement on MMSE but poorer cognition and sedation vs. placebo)",
      "Biomarkers": "No",
      "MOA Class": 2,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": ""
    },
    {
      "Phase": "Phase 2|Phase 3",
      "NCT #": "NCT03446001",
      "Drug Name": "TRx0237 (LMTX) - using the 4mg BID dose used as the placebo control group in the previous study",
      "Status": "Ongoing",
      "Biomarkers": "PET",
      "MOA Class": 3,
      "MOA Category": "b",
      "CADRO MOA Category": "B",
      "Geography": "1, 3, 4"
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT02477800",
      "Drug Name": "Aducanumab (BIIB037)",
      "Status": "Terminated (based on futility analysis not based on safety concerns; follow up visits and closing out study activities are completed)",
      "Biomarkers": "PET",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": ""
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT02484547",
      "Drug Name": "Aducanumab (BIIB037)",
      "Status": "Terminated (based on futility analysis not based on safety concerns; follow up visits and closing out study activities are completed)",
      "Biomarkers": "PET",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": ""
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT03486938",
      "Drug Name": "AGB101 (levetiracetam low dose; 1/15 of typical dose for epilepsy)",
      "Status": "Recruiting",
      "Biomarkers": "PET and MRI",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "M",
      "Geography": 1
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT02547818",
      "Drug Name": "ALZT-OP1a, ALZT-OP1b (cromolyn with and without ibuprofen)",
      "Status": "Ongoing",
      "Biomarkers": "CSF",
      "MOA Class": 3,
      "MOA Category": "a, f",
      "CADRO MOA Category": "F",
      "Geography": "1, 4, 7"
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT02442765",
      "Drug Name": "AVP-786",
      "Status": "Completed (positive results from phase 2 program, but phase 3 trials failed to reduce agitation",
      "Biomarkers": "No",
      "MOA Class": 2,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": ""
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT02442778",
      "Drug Name": "AVP-786",
      "Status": "Completed (positive results from phase 2 program, but phase 3 trials failed to reduce agitation",
      "Biomarkers": "no",
      "MOA Class": 2,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": ""
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT02446132",
      "Drug Name": "AVP-786",
      "Status": "Recruiting EXT",
      "Biomarkers": "No",
      "MOA Class": 2,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": "1, 3, 4, 7"
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT03393520",
      "Drug Name": "AVP-786 (d6-DM/quinidine)",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 2,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": "1, 3, 4, 7"
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT03548584",
      "Drug Name": "Brexpiprazole",
      "Status": "Recruiting",
      "Biomarkers": "CT or MRI",
      "MOA Class": 2,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 1
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT03594123",
      "Drug Name": "Brexpiprazole",
      "Status": "Recruiting- extension study",
      "Biomarkers": "no",
      "MOA Class": 2,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 1
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT03724942",
      "Drug Name": "Brexpiprazole",
      "Status": "Recruiting- extension study",
      "Biomarkers": "no",
      "MOA Class": 2,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 6
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT02670083",
      "Drug Name": "Crenezumab",
      "Status": "Completed (phase 3 program halted due to fuility)",
      "Biomarkers": "PET or CSF",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": ""
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT03114657",
      "Drug Name": "Crenezumab",
      "Status": "Completed (phase 3 program halted due to fuility)",
      "Biomarkers": "PET or CSF",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": ""
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT03491150",
      "Drug Name": "Crenezumab",
      "Status": "Completed (phase 3 program halted due to fuility)",
      "Biomarkers": "no; but the two double-blinded studies required CSF or PET as entry criterion",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": ""
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT02956486",
      "Drug Name": "E2609 (elenbecestat)",
      "Status": "Ongoing (but we know trial was suspended - Mission AD 1)",
      "Biomarkers": "PET or CSF",
      "MOA Class": 3,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": "1, 2, 3, 4, 6, 7"
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT03036280",
      "Drug Name": "E2609 (elenbecestat)",
      "Status": "Ongoing (but we know trial was suspended - Mission AD 2)",
      "Biomarkers": "PET or CSF",
      "MOA Class": 3,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": "1, 2, 3, 4, 5, 6, 7"
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT03108846",
      "Drug Name": "Escitalopram",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 2,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 3
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT02051608",
      "Drug Name": "gantenerumab",
      "Status": "Ongoing",
      "Biomarkers": "CSF",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": "1, 3, 4, 5, 6, 7"
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT01224106",
      "Drug Name": "gantenerumab",
      "Status": "Ongoing (dosing for Parts 1 and 2 was stopped after a planned futility interim analysis showed a low probability of meeting the primary outcome measure with the dose studied. The study has converted to open-label to investigate higher doses. Doses were 105mg and 225mg gantenerumab, switched to open label with doses up to 1200mg q4 weeks for 3 additional years",
      "Biomarkers": "No",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": "1, 2, 3, 4, 5, 7"
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT03444870",
      "Drug Name": "Gantenerumab SC",
      "Status": "Recruiting",
      "Biomarkers": "PET or CSF",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": "1, 2, 3, 4, 5, 6, 7"
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT03443973",
      "Drug Name": "Gantenerumab SC",
      "Status": "Recruiting",
      "Biomarkers": "PET or CSF",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": "1, 2, 3, 4, 5, 6"
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT03116126",
      "Drug Name": "Guanfacine",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 1,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 3
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT01872598",
      "Drug Name": "Masitinib",
      "Status": "Ongoing",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "f",
      "CADRO MOA Category": "F",
      "Geography": "3, 4"
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT02346201",
      "Drug Name": "Methylphenidate",
      "Status": "Recruiting",
      "Biomarkers": "No",
      "MOA Class": 2,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 1
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT03031184",
      "Drug Name": "Mirtazapine",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 2,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 3
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT03283059",
      "Drug Name": "Octohydroaminoacridine Succinate",
      "Status": "Recruiting",
      "Biomarkers": "MRI",
      "MOA Class": 1,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 5
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT02008357",
      "Drug Name": "Solanezumab",
      "Status": "Ongoing",
      "Biomarkers": "PET",
      "MOA Class": "c",
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": "1, 6, 7"
    },
    {
      "Phase": "Phase 3",
      "NCT #": "NCT03075241",
      "Drug Name": "Zolpidem & Zoplicone (studied separately)",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 2,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 2
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT01767311",
      "Drug Name": "BAN2401",
      "Status": "Ongoing (status changed from Completed status in 2019)",
      "Biomarkers": "PET or CSF",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": "1, 3, 5, 6"
    }
  ]
}